The Pathogenesis of Osteoporosis

Hormone Research in Paediatrics

Volumn 48, Issue 5, 1997, Pages 79-82

  Eriksen, E F ^a   Langdahl, B L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Ageing; Bone mass; Menopause; Oestrogen; Osteoblast insufficiency; Osteoporosis

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

BONE ATROPHY; BONE MASS; BONE REMODELING; CALCIUM ABSORPTION; CONFERENCE PAPER; DIET; GENE MUTATION; MENOPAUSE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

BONE AND BONES; HUMANS; OSTEOPOROSIS;

EID: 0030728134     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000191333     Document Type: Article

References (24)

1. Kanis JA, Mellon U, Christiansen C, Johnston CC, Khallaev N: The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
2. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberi S: Genetic determinants of bone mass in adults: A twin study. J Clin Invest 1987;80:706-710.
3. Matkovic V: Calcium metabolism and calcium requirements during skeletal modelling and consolidation of bone mass. Am J Clin Nutr 1991;54:245S-260S.
4. Johnston CC Jr, Miller JZ, Slcmenda CW, Reister TK, Hui S, Christian JC, Peacock M: Calcium supplementation and increases in bone mineral density in children [sec comments], N Engl J Med 1992;327:82-87.
5. Ruiz JC, Mandel C, Garabcdian M: Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescents. J Bone Miner Res 1995:10:675-682.
6. Lutz J, Tesar R: Mother-daughter pairs: spinal and femoral bone densities and dietary intakes. Am J Clin Nutr 1990:52:872-877.
7. Eriksen EF, Mosckildc L, Mclscn F: Trabecular bone resorption depth decreases with age: differences between normal males and females. Bone 1985;6:141-146.
8. Shevde NK, Pike JW: Estrogen modulates the recruitment of myelopoietic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis. Blood 1996:87: 2683-2692.
9. Kelsey JL: Risk factors for osteoporosis and associated fractures. Public Health Rep 1989; 104(suppl):14-20.
10. Girasole G, Jilka RL, Passcri G, Boswell S, Boder G, Williams DC, Manolagas SC: 17 beta-cstradiol inhibits intcrlcukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992;89:883-891.
11. Chaudhary LR, Spelsberg TC, Riggs BL: Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol. Endocrinology 1992;130:2528-2534.
12. Jilka RL, Hangoc G, Girasole G. Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC: Increased osteoclast development after estrogen loss: mediation by inter-lcukin-6. Science 1992:257:88-91.
13. Mangolagas SC, Bellido T, Jilka RL: New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL-6 and gp 130. Int J Im-munopharmacol 1995;17:109-116.
14. Abrahamscn B, Bendtzen K, Beck-Nielsen H: Estrogen retards bone loss without affecting the release of IL-1 or IL-lra. Bone 1997,20:251-258.
15. Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL: Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab 1994:79:707-711.
16. Lips P, Courpron P, Meunier P: Mean wall thickness of trabecular bone packets. Metab Bone Dis Rel Res 1978;2:13-16.
17. Eriksen EF, Hodgson SF, Eastell R, Cadel SL, O'Fallon WM. Riggs BL: Cancellous bone remodelling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation. resorption, and bone loss at tissue and cellular levels [sec comments]. J Bone Miner Res 1990:5:311-319.
18. Kasscm M, Brixen K, Blum W, Mosekilde L, Eriksen EF: No evidence for reduced spontaneous or growth-hormonc-stimulated serum levels of insulin-like growth factor (IGFFL IGF-1I) or IGF binding protein 3 in women with spinal osteoporosis. Eur J Endocrinol 1994; 131:150-155.
19. Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF: Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. J Bone Miner Res 1994:9:1365-1370.
20. Ljunghall S, Johansson AG, Burman P, Kampe O, Lindh E, Karlsson FA: Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J Intern Med 1992;232:59-64.
21. Meunicr PJ, Chapuy MC, Arlot ME, Delmas PD, Duboeuf F: Can we stop bone loss and prevent hip fractures in the elderly? Osteoporos Int 1994;4(suppl 1):71-76.
22. Grant SFA, Reid DM, Blake G, Herd R, Fogel-man I, Ralston SH: Reduced bone density and osteoporosis associated with a polymorphic SP1 binding site in the collagen type 1 alfa 1 gene. Nature Genetics 1996:14:203-205.
23. Langdahl BL, Knudsen JY, Jensen HK, Gre-gerscn N, Eriksen EF: A sequence variation: 713-8delC in the transforming growth factor-betal gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997: 20:289-294.
24. Kobayashi S, Inouc S, Hosoi T, Ouchi Y, Shira-ki M, Orimo H: Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996:11:306-311.